Ladenburg Thalmann Downgrades CONMED (CNMD) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/12/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Former emir of Qatar, Sheikh Hamad bin Khalifa Al Thani, dies at 74
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Wall Street ends higher as investors turn to earnings season
Conmed (CNMD) Misses Q1 EPS by 2c, Offers FY15 Guidance
April 22, 2015 4:52 PM EDTConmed (NASDAQ: CNMD) reported Q1 EPS of $0.42, $0.02 worse than the analyst estimate of $0.44. Revenue for the quarter came in at $177.9 million versus the consensus estimate of $176.16 million.
Conmed sees FY2015 EPS of $1.82-$1.92, versus the consensus of $1.86. Conmed sees FY2015 revenue of $723-738... More
